A detailed history of Umb Bank, N.A. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 282 shares of CPRX stock, worth $6,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
282
Previous 142 98.59%
Holding current value
$6,223
Previous $2,000 150.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$15.19 - $21.35 $2,126 - $2,989
140 Added 98.59%
282 $5,000
Q2 2024

Jul 29, 2024

BUY
$14.68 - $16.92 $1,350 - $1,556
92 Added 184.0%
142 $2,000
Q1 2024

Apr 26, 2024

BUY
$13.18 - $17.11 $659 - $855
50 New
50 $0

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.27B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.